Analyst Ratings for Lineage Cell Therapeutics Inc. (LCTX)
LCTX Rating Summary
LCTX Price Target Summary
- Highest: $9.00 (H.C. Wainwright)
- Lowest: $3.00 (Maxim Group)
- Average: $6.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$6.00 (+395.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$6.00 (+395.9%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/28/2026 | Canaccord | John Newman | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.55 (1.21) |
-21.94% | Details |
| 11/18/2024 | D. Boral Capital | Jason Kolbert | New Coverage | Buy (N/A) |
3.00 (N/A) |
0.86 (1.21) |
40.7% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
